Barclays Maintains Equal-Weight on Ambev, Lowers Price Target to $3
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Benjamin Theurer maintains Ambev (NYSE:ABEV) with a Equal-Weight and lowers the price target from $3.5 to $3.
Barclays analyst Benjamin Theurer maintains Ambev (NYSE:ABEV) with a Equal-Weight and lowers the price target from $3.5 to $3.
